Table 1.
PC (Rate/HPF) |
pCRC (Rate/HPF) |
||||||
---|---|---|---|---|---|---|---|
Cell Division Rate | Mean ± SD | 95% CI | n | Mean ± SD | 95% CI | n | p |
Proliferation | |||||||
Ki-67 | 0.16 ± 0.10 | 0.12–0.19 | 35 | 0.30 ± 0.15 | 0.24–0.37 | 23 | 0.0006 |
PCNA | 0.17 ± 0.10 | 0.14–0.21 | 39 | 0.48 ± 0.13 | 0.43 ± 0.52 | 39 | <0.0001 |
Cyclin D1 | 0.10 ± 0.04 | 0.09–0.12 | 39 | 0.20 ± 0.07 | 0.18–0.22 | 41 | <0.0001 |
Senescence | |||||||
H3K9me3 | 0.39 ± 0.18 | 0.33–0.45 | 37 | 0.05 ± 0.09 | 0–0.11 | 10 | <0.0001 |
p21Cip1 | 0.23 ± 0.09 | 0.20–0.26 | 39 | 0.16 ± 0.12 | 0.12–0.20 | 42 | 0.0005 |
CDKN2A | 0.60 ± 0.12 | 0.56–0.64 | 40 | 0.22 ± 0.12 | 0.18–0.26 | 42 | <0.0001 |
Abbreviations: PC, peritoneal carcinomatosis; pCRC, primary colorectal cancer; Rate, ratio of positive stained cancer cells divided by all cancer cells; HPF, high-power field; SD, standard deviation; CI, confidence interval; Ki67, PCNA and cyclin D1 as proliferation markers; H3K9me3, p21Cip1 and CDKN2A as senescence markers.